Sustained Long-Term Benefit of Gene Therapy for SMA
For children with spinal muscular atrophy (SMA), gene therapy with onasemnogene abeparvovec (Zolgensma, Novartis) provides long-lasting benefits with a favorable …
Home ยป
For children with spinal muscular atrophy (SMA), gene therapy with onasemnogene abeparvovec (Zolgensma, Novartis) provides long-lasting benefits with a favorable …
Breast cancer survivors with a higher risk of cancer recurrence based on genomic testing may experience greater fear of their …
The current COVID-19 outbreak is one of the worst pandemics in history and has claimed millions of lives across the …
A new study has uncovered genetic changes in a group of similar severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants …
The National Cancer Institute's Genomic Data Commons (GDC), launched in 2016 by then-Vice President Joseph Biden and hosted at the …
A new study led by researchers at Oxford and Guangdong Centre for Diseases Control and Prevention describes the epidemiology and …
Acute erythroid leukemia (AEL) is a high-risk cancer with a dismal prognosis, uncertain genetic basis and controversy surrounding the diagnosis. …